v3.26.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2026
Apr. 30, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-42001  
Entity Registrant Name Contineum Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 27-1467257  
Entity Address, Address Line One 3565 General Atomics Court, Suite 200  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code 858  
Local Phone Number 333-5280  
Title of 12(b) Security Class A Common Stock, $0.001 par value per share  
Trading Symbol CTNM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Central Index Key 0001855175  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Class A    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   32,723,877
Class B    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   4,662,500